Glomerulosclerosis, Focal Segmental
Nephrology·MeSH: Glomerulosclerosis, Focal Segmental
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| vx-147 | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Frequently asked questions
How many drugs are in development for Glomerulosclerosis, Focal Segmental?
BioSniper tracks 1 drug in development for Glomerulosclerosis, Focal Segmental across 1 company.
How many clinical trials target Glomerulosclerosis, Focal Segmental?
There are 1 clinical trial targeting Glomerulosclerosis, Focal Segmental tracked by BioSniper.
Deep-dive into Glomerulosclerosis, Focal Segmental
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis